Yeast Beta-Glucan Market Was Valued at USD 88.9 Million in 2021, Rising Demand for Probiotic Functional Foods

According to Precision Business Insights (PBI) latest report, the global yeast beta-glucan market is expected to be worth USD 94.7 million in 2022, growing at a 6.7% CAGR from 2022 to 2028. Global yeast beta-glucan market is segmented into the following types: Global Yeast Beta-Glucan Market by Source ((1,3) Beta Glucan, (1,3) & (1,6) Beta Glucan), By Application (Food & Beverages, Personal Care, Pharmaceuticals, Others), and Geography. The growing demand for nutritional and dietary supplements has anticipated the growth of the yeast beta-glucan market over the forecasting period. Moreover, rise in the incidence of nutritional disorders and immunosuppressant diseases, increase in R&D for the launch of novel products, and grow in disposable income are anticipated to burgeon the growth of the market over the forecast years. For instance, In December 2020 Lallemand Inc's subsidiary, Danstar Ferment AG has signed an agreement to purchase Biotec BetaGlucans AS (BBG), a wholly owned subsidiary of the ArticZymes Technologies ASA (AZT) company.

View Detailed Report Description at https://precisionbusinessinsights.com/market-reports/yeast-extract-and-beta-glucan-market/

Personal Care Dominates the Yeast Beta-Glucan Market
Personal care segment expected to dominate market share and it is expected to grow with a CAGR x% from 2022-2028. The segment is expected to grow drastically due to increase in the usage of yeast beta-glucan in cosmetic products such as sun-care, moisturizing, and repairing products. Moreover, yeast beta-glucan aids in the maintenance or enhancement of the immune system's effectiveness such as skin's defensive system, promote natural healing processes, and minimize skin irritation when used in cosmetics. In addition, increase in the use of beta-glucan in probiotics and other nutritional supplements also immense boost to the market over the forecast years.

Asia Pacific leads Yeast Beta-Glucan Market
Asia Pacific holds the significant share in the Yeast Beta-Glucan market during the forecast period due to rise in awareness about nutritional supplements, cosmetic products, and pharmaceuticals. The increased demand for food items with improved nutritional value, together with expanding consumer buying power, is predicted to boost industry growth demand. Europe holds a significant share in yeast beta-glucan market owing to rise in demand for cosmetics in Germany, France, Spain, UK, and other EU countries, rise in disposable income, and development and launch of newer products by the market players in the region

New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players
Yeast Beta-Glucan market further reveals that the key players increasingly adopting strategies such as launch of newer products, frequent product approvals, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. In May 2018, Ohly (Germany) collaborated with Biotec Pharmacon ASA's (Norway), to investigate the untapped opportunities in the land animal feed area. The company developed the use of yeast beta-glucan in this market segment.

Request sample report at https://precisionbusinessinsights.com/request-sample/?product_id=23945

Key player's profiles in the report Cargill, Incorporated, Lesaffre Human Care, EMD Millipore, Biorigin, Kerry Group plc, Lallemand, Inc., Specialty Biotech Co., Ltd., Van Wankum Ingredients, Angel Yeast Co., Ltd., Leiber

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.